These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9611252)

  • 61. Dysregulation of myeloid-specific transcription factors in congenital neutropenia.
    Skokowa J; Welte K
    Ann N Y Acad Sci; 2009 Sep; 1176():94-100. PubMed ID: 19796237
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intestinal maturation in mice lacking CCAAT/enhancer-binding protein alpha (C/EPBalpha).
    Oesterreicher TJ; Leeper LL; Finegold MJ; Darlington GJ; Henning SJ
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1165-71. PubMed ID: 9494081
    [TBL] [Abstract][Full Text] [Related]  

  • 63. PU.1 but not ets-2 is essential for macrophage development from embryonic stem cells.
    Henkel GW; McKercher SR; Yamamoto H; Anderson KL; Oshima RG; Maki RA
    Blood; 1996 Oct; 88(8):2917-26. PubMed ID: 8874188
    [TBL] [Abstract][Full Text] [Related]  

  • 64. PU. 1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation.
    Olson MC; Scott EW; Hack AA; Su GH; Tenen DG; Singh H; Simon MC
    Immunity; 1995 Dec; 3(6):703-14. PubMed ID: 8777716
    [TBL] [Abstract][Full Text] [Related]  

  • 65. PU.1 determines the self-renewal capacity of erythroid progenitor cells.
    Back J; Dierich A; Bronn C; Kastner P; Chan S
    Blood; 2004 May; 103(10):3615-23. PubMed ID: 14739214
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neutrophils deficient in PU.1 do not terminally differentiate or become functionally competent.
    Anderson KL; Smith KA; Pio F; Torbett BE; Maki RA
    Blood; 1998 Sep; 92(5):1576-85. PubMed ID: 9716585
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dual regulation of SPI1/PU.1 transcription factor by heat shock factor 1 (HSF1) during macrophage differentiation of monocytes.
    Jego G; Lanneau D; De Thonel A; Berthenet K; Hazoumé A; Droin N; Hamman A; Girodon F; Bellaye PS; Wettstein G; Jacquel A; Duplomb L; Le Mouël A; Papanayotou C; Christians E; Bonniaud P; Lallemand-Mezger V; Solary E; Garrido C
    Leukemia; 2014 Aug; 28(8):1676-86. PubMed ID: 24504023
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dose-Rate-Dependent PU.1 Inactivation to Develop Acute Myeloid Leukemia in Mice Through Persistent Stem Cell Proliferation After Acute or Chronic Gamma Irradiation.
    Ojima M; Hirouchi T; Etani R; Ariyoshi K; Fujishima Y; Kai M
    Radiat Res; 2019 Dec; 192(6):612-620. PubMed ID: 31560640
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages.
    Lloberas J; Soler C; Celada A
    Immunol Today; 1999 Apr; 20(4):184-9. PubMed ID: 10203717
    [No Abstract]   [Full Text] [Related]  

  • 70. C/EBPalpha induces PU.1 and interacts with AP-1 and NF-kappaB to regulate myeloid development.
    Friedman AD
    Blood Cells Mol Dis; 2007; 39(3):340-3. PubMed ID: 17669672
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors.
    Radomska HS; Huettner CS; Zhang P; Cheng T; Scadden DT; Tenen DG
    Mol Cell Biol; 1998 Jul; 18(7):4301-14. PubMed ID: 9632814
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Spi-B can functionally replace PU.1 in myeloid but not lymphoid development.
    Dahl R; Ramirez-Bergeron DL; Rao S; Simon MC
    EMBO J; 2002 May; 21(9):2220-30. PubMed ID: 11980719
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Disruption of the C/EBPα-miR-182 balance impairs granulocytic differentiation.
    Wurm AA; Zjablovskaja P; Kardosova M; Gerloff D; Bräuer-Hartmann D; Katzerke C; Hartmann JU; Benoukraf T; Fricke S; Hilger N; Müller AM; Bill M; Schwind S; Tenen DG; Niederwieser D; Alberich-Jorda M; Behre G
    Nat Commun; 2017 Jun; 8(1):46. PubMed ID: 28663557
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reciprocal roles for CCAAT/enhancer binding protein (C/EBP) and PU.1 transcription factors in Langerhans cell commitment.
    Iwama A; Osawa M; Hirasawa R; Uchiyama N; Kaneko S; Onodera M; Shibuya K; Shibuya A; Vinson C; Tenen DG; Nakauchi H
    J Exp Med; 2002 Mar; 195(5):547-58. PubMed ID: 11877478
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Structural mechanism of synergistic targeting of the CX3CR1 nucleosome by PU.1 and C/EBPα.
    Lian T; Guan R; Zhou BR; Bai Y
    Nat Struct Mol Biol; 2024 Apr; 31(4):633-643. PubMed ID: 38267599
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Transcription factors that regulate monocyte/macrophage differentiation.
    Valledor AF; Borràs FE; Cullell-Young M; Celada A
    J Leukoc Biol; 1998 Apr; 63(4):405-17. PubMed ID: 9544570
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Commitment to the monocytic lineage occurs in the absence of the transcription factor PU.1.
    Henkel GW; McKercher SR; Leenen PJ; Maki RA
    Blood; 1999 May; 93(9):2849-58. PubMed ID: 10216079
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Growth factor independence-1 (Gfi-1) plays a role in mediating specific granule deficiency (SGD) in a patient lacking a gene-inactivating mutation in the C/EBPepsilon gene.
    Khanna-Gupta A; Sun H; Zibello T; Lee HM; Dahl R; Boxer LA; Berliner N
    Blood; 2007 May; 109(10):4181-90. PubMed ID: 17244686
    [TBL] [Abstract][Full Text] [Related]  

  • 79. PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain.
    Cook WD; McCaw BJ; Herring C; John DL; Foote SJ; Nutt SL; Adams JM
    Blood; 2004 Dec; 104(12):3437-44. PubMed ID: 15304397
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Critical role for the Oct-2/OCA-B partnership in Ig-secreting cells.
    Salas M; Eckhardt LA
    J Immunol; 2003 Dec; 171(12):6589-98. PubMed ID: 14662861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.